Genetic Tests to Detect and Predict Recurrence Likelihood of Lung Cancer
Filed in archive Diagnostics, Methodologies and Instrumentation , Genomics, Proteomics and Bioinformatics on May 25, 2008
Two research studies presented during the recently held American Thoracic Society's 2008 International Conference in Toronto point to diagnostic tests for lung cancer: a blood test for accurately detecting lung cancer in its early stages, and a genetic test to predict the likelihood that cancer would recur in patients whose non-small cell lung cancer has been surgically removed.
The blood test for detecting lung cancer is based on the gene expression of white blood cells. A 15-gene array has been found to have the highest accuracy, at 87 percent. The test for predicting the likelihood of cancer recurrence was based on five survival gene signatures found in 21 patients.
The accuracy of the tested signatures ranged from 40 to 80 percent and varied with the type of tumor. A 42-gene signature, for instance, was 82 percent accurate in predicting survival with lung adenocarcinoma, but only 70 percent accurate in predicting survival with squamous cell carcinoma.

Tags: cancer lung+cancer diagnostics blood+test genetics genomics genetic+test lung genetic+tests
Vote for Genetic Tests to Detect and Predict Recurrence Likelihood of Lung Cancer:
|
Rating: 5.75 out of 4 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
